RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Liontrust Investment Partners LLP's Holding History (CIK: 0001544204)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 702,386 Value ($000) $3,554 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 595,055 Value ($000) $3,148 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 931,727 Value ($000) $6,298 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 990,000 Value ($000) $7,425 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 990,000 Value ($000) $7,425 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 750,000 Value ($000) $7,478 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 515,000 Value ($000) $5,078 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 520,000 Value ($000) $3,978 Avg Close $9.98 Range $6.44 - $16.75